Aging is associated with impaired mitochondrial function caused by accumula
tion of oxygen free radical-induced mitochondrial (Mt) DNA mutations. One p
revailing theory is that age-associated diseases, including Alzheimer's dis
ease (AD), may be precipitated, propagated, or caused by impaired mitochond
rial function. To investigate the role of MtDNA relative to genomic (Gn) DN
A damage in AD, temporal lobe samples from postmortem AD (n = 37) and contr
ol (n = 25) brains were analyzed for MtDNA and GnDNA fragmentation, mitocho
ndrial protein and cytochrome oxidase expression, MitoTracker Green fluores
cence (to assess mitochondrial mass/abundance), and 8-oxo-7,8-dihydro-2'-de
oxyguanosine (8-OHdG) immunoreactivity. Brains with AD had more extensive n
icking and fragmentation of both MtDNA and GnDNA as demonstrated by agarose
gel electrophoresis, end-labeling, and the in situ terminal deoxynucleotid
e transferase end-labeling (TUNEL) assay, and only the brains with AD had d
etectable 8-OHdG immunoreactivity in cortical neurons. Increased MtDNA dama
ge in AD was associated with reduced MtDNA content, as demonstrated by semi
quantitative PCR analysis and reduced levels of Mt protein and cytochrome o
xidase expression by Western blot analysis or immunohistochemical staining
with image analysis. The finding of reduced MitoTracker Green fluorescence
in AD brains provided additional evidence that reduced Mt mass/abundance oc
curs with AD neurodegeneration. The presence of increased MtDNA and GnDNA d
amage in AD suggest dual cell death cascades in AD. Impaired mitochondrial
function caused by MtDNA damage may render brain cells in AD more susceptib
le to oxidative injury and thereby provide a mechanism by which systemic or
environmental factors could influence the course of disease.